287 related articles for article (PubMed ID: 24702826)
1. Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis.
Das M; Mei X; Jayaraman S; Atkinson D; Gursky O
FEBS J; 2014 Jun; 281(11):2525-42. PubMed ID: 24702826
[TBL] [Abstract][Full Text] [Related]
2. The crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on amyloid formation by the N-terminal fragment.
Gursky O; Mei X; Atkinson D
Biochemistry; 2012 Jan; 51(1):10-8. PubMed ID: 22229410
[TBL] [Abstract][Full Text] [Related]
3. Structural Stability and Local Dynamics in Disease-Causing Mutants of Human Apolipoprotein A-I: What Makes the Protein Amyloidogenic?
Das M; Wilson CJ; Mei X; Wales TE; Engen JR; Gursky O
J Mol Biol; 2016 Jan; 428(2 Pt B):449-62. PubMed ID: 26562506
[TBL] [Abstract][Full Text] [Related]
4. Chameleon 'aggregation-prone' segments of apoA-I: A model of amyloid fibrils formed in apoA-I amyloidosis.
Louros NN; Tsiolaki PL; Griffin MD; Howlett GJ; Hamodrakas SJ; Iconomidou VA
Int J Biol Macromol; 2015 Aug; 79():711-8. PubMed ID: 26049118
[TBL] [Abstract][Full Text] [Related]
5. Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation.
Adachi E; Nakajima H; Mizuguchi C; Dhanasekaran P; Kawashima H; Nagao K; Akaji K; Lund-Katz S; Phillips MC; Saito H
J Biol Chem; 2013 Jan; 288(4):2848-56. PubMed ID: 23233678
[TBL] [Abstract][Full Text] [Related]
6. Molecular Insights into Human Hereditary Apolipoprotein A-I Amyloidosis Caused by the Glu34Lys Mutation.
Morgado I; Panahi A; Burwash AG; Das M; Straub JE; Gursky O
Biochemistry; 2018 Oct; 57(39):5738-5747. PubMed ID: 30184436
[TBL] [Abstract][Full Text] [Related]
7. Hot spots in apolipoprotein A-II misfolding and amyloidosis in mice and men.
Gursky O
FEBS Lett; 2014 Mar; 588(6):845-50. PubMed ID: 24561203
[TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I.
Chan GK; Witkowski A; Gantz DL; Zhang TO; Zanni MT; Jayaraman S; Cavigiolio G
J Biol Chem; 2015 Apr; 290(17):10958-71. PubMed ID: 25759391
[TBL] [Abstract][Full Text] [Related]
9. Effects of Disease-Causing Mutations on the Conformation of Human Apolipoprotein A-I in Model Lipoproteins.
Wilson CJ; Das M; Jayaraman S; Gursky O; Engen JR
Biochemistry; 2018 Jul; 57(30):4583-4596. PubMed ID: 30004693
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.
Mizuguchi C; Nakagawa M; Namba N; Sakai M; Kurimitsu N; Suzuki A; Fujita K; Horiuchi S; Baba T; Ohgita T; Nishitsuji K; Saito H
J Biol Chem; 2019 Sep; 294(36):13515-13524. PubMed ID: 31341020
[TBL] [Abstract][Full Text] [Related]
11. Identification of an amyloid fibril forming peptide comprising residues 46-59 of apolipoprotein A-I.
Wong YQ; Binger KJ; Howlett GJ; Griffin MD
FEBS Lett; 2012 Jun; 586(13):1754-8. PubMed ID: 22609356
[TBL] [Abstract][Full Text] [Related]
12. Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.
Mizuguchi C; Ogata F; Mikawa S; Tsuji K; Baba T; Shigenaga A; Shimanouchi T; Okuhira K; Otaka A; Saito H
J Biol Chem; 2015 Aug; 290(34):20947-20959. PubMed ID: 26175149
[TBL] [Abstract][Full Text] [Related]
13. Fibrillar conformation of an apolipoprotein A-I variant involved in amyloidosis and atherosclerosis.
Gisonno RA; Prieto ED; Gorgojo JP; Curto LM; Rodriguez ME; Rosú SA; Gaddi GM; Finarelli GS; Cortez MF; Schinella GR; Tricerri MA; Ramella NA
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129515. PubMed ID: 31904503
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein A-I induced amyloidosis.
Genschel J; Haas R; Pröpsting MJ; Schmidt HH
FEBS Lett; 1998 Jul; 430(3):145-9. PubMed ID: 9688527
[TBL] [Abstract][Full Text] [Related]
15. Heparin and Methionine Oxidation Promote the Formation of Apolipoprotein A-I Amyloid Comprising α-Helical and β-Sheet Structures.
Townsend D; Hughes E; Hussain R; Siligardi G; Baldock S; Madine J; Middleton DA
Biochemistry; 2017 Mar; 56(11):1632-1644. PubMed ID: 27992182
[TBL] [Abstract][Full Text] [Related]
16. Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations.
Gomaraschi M; Obici L; Simonelli S; Gregorini G; Negrinelli A; Merlini G; Franceschini G; Calabresi L
Clin Chim Acta; 2011 Jun; 412(13-14):1262-5. PubMed ID: 21458433
[TBL] [Abstract][Full Text] [Related]
17. Mutation mapping of apolipoprotein A-I structure assisted with the putative cholesterol recognition regions.
Dergunov AD
Biochim Biophys Acta; 2013 Oct; 1834(10):2030-5. PubMed ID: 23806608
[TBL] [Abstract][Full Text] [Related]
18. On the Aggregation of Apolipoprotein A-I.
Frankel R; Sparr E; Linse S
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955915
[TBL] [Abstract][Full Text] [Related]
19. Human apolipoprotein A-I-derived amyloid: its association with atherosclerosis.
Ramella NA; Rimoldi OJ; Prieto ED; Schinella GR; Sanchez SA; Jaureguiberry MS; Vela ME; Ferreira ST; Tricerri MA
PLoS One; 2011; 6(7):e22532. PubMed ID: 21811627
[TBL] [Abstract][Full Text] [Related]
20. Effects of the known pathogenic mutations on the aggregation pathway of the amyloidogenic peptide of apolipoprotein A-I.
Raimondi S; Guglielmi F; Giorgetti S; Di Gaetano S; Arciello A; Monti DM; Relini A; Nichino D; Doglia SM; Natalello A; Pucci P; Mangione P; Obici L; Merlini G; Stoppini M; Robustelli P; Tartaglia GG; Vendruscolo M; Dobson CM; Piccoli R; Bellotti V
J Mol Biol; 2011 Apr; 407(3):465-76. PubMed ID: 21296086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
